Novartis AGNVSNYSE
Loading
Revenue minus cost of goods sold
3Y CAGR
+8.9%/yr
vs +0.2%/yr prior
5Y CAGR
+3.4%/yr
Recent acceleration
Acceleration
+8.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
3 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $41.12B | +5.7% |
| 2024 | $38.90B | +13.8% |
| 2023 | $34.19B | +7.2% |
| 2022 | $31.88B | -1.1% |
| 2021 | $32.24B | -7.3% |
| 2020 | $34.78B | +1.5% |
| 2019 | $34.25B | +8.4% |
| 2018 | $31.59B | +6.1% |
| 2017 | $29.77B | -6.7% |
| 2016 | $31.92B | - |